Allogeneic Transplants in Follicular Lymphoma: Higher Risk of Disease Progression after Reduced-Intensity Compared to Myeloablative Conditioning

Parameswaran Hari, Jeanette Carreras, Mei Jie Zhang, Robert Peter Gale, Brian J. Bolwell, Christopher N. Bredeson, Linda J. Burns, Mitchell S. Cairo, César O. Freytes, Steven C. Goldstein, Gregory A. Hale, David J. Inwards, Charles F. LeMaistre, Dipnarine Maharaj, David I. Marks, Harry C. Schouten, Shimon Slavin, Julie Marie Vose, Hillard M. Lazarus, Koen van Besien

Research output: Contribution to journalArticle

123 Citations (Scopus)

Abstract

Reduced-intensity conditioning (RIC) regimens have been increasingly used for allogeneic hematopoietic stem cell transplantation (HSCT) in follicular lymphoma (FL). We compared traditional myeloablative conditioning regimens to RIC in FL. Outcomes of HLA-identical sibling HSCT for FL in 208 recipients reported to the Center for International Blood and Marrow Transplant Research (CIBMTR) between 1997 and 2002 were studied. Conditioning regimens were categorized as myeloablative (N = 120) or RIC (N = 88). Use of RIC regimens increased from <10% of transplants in 1997 to >80% in 2002 signaling a major shift in practice. Patients receiving RIC were older and had a longer interval from diagnosis to transplant. These differences did not correlate with outcomes. Median follow-up of survivors was 50 months (4-96 months) after myeloablative conditioning versus 35 months (4-82 months) after RIC (P < .001). At 3 years, overall survival (OS) for the myeloablative and RIC cohorts were 71 (63%-79%) and 62 (51%-72%; P = .15) and progression free survival (PFS), 67 (58%-75%) and 55 (44%-65%; P = .07), respectively. Lower Karnofsky performance score (KPS) and resistance to chemotherapy were associated with higher treatment-related mortality (TRM) and lower OS and PFS. On multivariate analysis, an increased risk of lymphoma progression after RIC was observed (relative risk = 2.97, P = .04). RIC has become the de facto standard in allogeneic HSCT for FL, and appears to result in similar long-term outcomes. Although disease-free survival (DPS) is similar compared to myeloablative conditioning, an increased risk of late disease progression after RIC is concerning.

Original languageEnglish (US)
Pages (from-to)236-245
Number of pages10
JournalBiology of Blood and Marrow Transplantation
Volume14
Issue number2
DOIs
StatePublished - Feb 1 2008

Fingerprint

Follicular Lymphoma
Disease Progression
Transplants
Hematopoietic Stem Cell Transplantation
Disease-Free Survival
Conditioning (Psychology)
Survival
Survivors
Siblings
Lymphoma

Keywords

  • Allogeneic
  • Follicular lymphoma
  • Nonmyeloablative

ASJC Scopus subject areas

  • Hematology
  • Transplantation

Cite this

Allogeneic Transplants in Follicular Lymphoma : Higher Risk of Disease Progression after Reduced-Intensity Compared to Myeloablative Conditioning. / Hari, Parameswaran; Carreras, Jeanette; Zhang, Mei Jie; Gale, Robert Peter; Bolwell, Brian J.; Bredeson, Christopher N.; Burns, Linda J.; Cairo, Mitchell S.; Freytes, César O.; Goldstein, Steven C.; Hale, Gregory A.; Inwards, David J.; LeMaistre, Charles F.; Maharaj, Dipnarine; Marks, David I.; Schouten, Harry C.; Slavin, Shimon; Vose, Julie Marie; Lazarus, Hillard M.; van Besien, Koen.

In: Biology of Blood and Marrow Transplantation, Vol. 14, No. 2, 01.02.2008, p. 236-245.

Research output: Contribution to journalArticle

Hari, P, Carreras, J, Zhang, MJ, Gale, RP, Bolwell, BJ, Bredeson, CN, Burns, LJ, Cairo, MS, Freytes, CO, Goldstein, SC, Hale, GA, Inwards, DJ, LeMaistre, CF, Maharaj, D, Marks, DI, Schouten, HC, Slavin, S, Vose, JM, Lazarus, HM & van Besien, K 2008, 'Allogeneic Transplants in Follicular Lymphoma: Higher Risk of Disease Progression after Reduced-Intensity Compared to Myeloablative Conditioning', Biology of Blood and Marrow Transplantation, vol. 14, no. 2, pp. 236-245. https://doi.org/10.1016/j.bbmt.2007.11.004
Hari, Parameswaran ; Carreras, Jeanette ; Zhang, Mei Jie ; Gale, Robert Peter ; Bolwell, Brian J. ; Bredeson, Christopher N. ; Burns, Linda J. ; Cairo, Mitchell S. ; Freytes, César O. ; Goldstein, Steven C. ; Hale, Gregory A. ; Inwards, David J. ; LeMaistre, Charles F. ; Maharaj, Dipnarine ; Marks, David I. ; Schouten, Harry C. ; Slavin, Shimon ; Vose, Julie Marie ; Lazarus, Hillard M. ; van Besien, Koen. / Allogeneic Transplants in Follicular Lymphoma : Higher Risk of Disease Progression after Reduced-Intensity Compared to Myeloablative Conditioning. In: Biology of Blood and Marrow Transplantation. 2008 ; Vol. 14, No. 2. pp. 236-245.
@article{3dff70f086a644189a51f0c4d68f7d03,
title = "Allogeneic Transplants in Follicular Lymphoma: Higher Risk of Disease Progression after Reduced-Intensity Compared to Myeloablative Conditioning",
abstract = "Reduced-intensity conditioning (RIC) regimens have been increasingly used for allogeneic hematopoietic stem cell transplantation (HSCT) in follicular lymphoma (FL). We compared traditional myeloablative conditioning regimens to RIC in FL. Outcomes of HLA-identical sibling HSCT for FL in 208 recipients reported to the Center for International Blood and Marrow Transplant Research (CIBMTR) between 1997 and 2002 were studied. Conditioning regimens were categorized as myeloablative (N = 120) or RIC (N = 88). Use of RIC regimens increased from <10{\%} of transplants in 1997 to >80{\%} in 2002 signaling a major shift in practice. Patients receiving RIC were older and had a longer interval from diagnosis to transplant. These differences did not correlate with outcomes. Median follow-up of survivors was 50 months (4-96 months) after myeloablative conditioning versus 35 months (4-82 months) after RIC (P < .001). At 3 years, overall survival (OS) for the myeloablative and RIC cohorts were 71 (63{\%}-79{\%}) and 62 (51{\%}-72{\%}; P = .15) and progression free survival (PFS), 67 (58{\%}-75{\%}) and 55 (44{\%}-65{\%}; P = .07), respectively. Lower Karnofsky performance score (KPS) and resistance to chemotherapy were associated with higher treatment-related mortality (TRM) and lower OS and PFS. On multivariate analysis, an increased risk of lymphoma progression after RIC was observed (relative risk = 2.97, P = .04). RIC has become the de facto standard in allogeneic HSCT for FL, and appears to result in similar long-term outcomes. Although disease-free survival (DPS) is similar compared to myeloablative conditioning, an increased risk of late disease progression after RIC is concerning.",
keywords = "Allogeneic, Follicular lymphoma, Nonmyeloablative",
author = "Parameswaran Hari and Jeanette Carreras and Zhang, {Mei Jie} and Gale, {Robert Peter} and Bolwell, {Brian J.} and Bredeson, {Christopher N.} and Burns, {Linda J.} and Cairo, {Mitchell S.} and Freytes, {C{\'e}sar O.} and Goldstein, {Steven C.} and Hale, {Gregory A.} and Inwards, {David J.} and LeMaistre, {Charles F.} and Dipnarine Maharaj and Marks, {David I.} and Schouten, {Harry C.} and Shimon Slavin and Vose, {Julie Marie} and Lazarus, {Hillard M.} and {van Besien}, Koen",
year = "2008",
month = "2",
day = "1",
doi = "10.1016/j.bbmt.2007.11.004",
language = "English (US)",
volume = "14",
pages = "236--245",
journal = "Biology of Blood and Marrow Transplantation",
issn = "1083-8791",
publisher = "Elsevier Inc.",
number = "2",

}

TY - JOUR

T1 - Allogeneic Transplants in Follicular Lymphoma

T2 - Higher Risk of Disease Progression after Reduced-Intensity Compared to Myeloablative Conditioning

AU - Hari, Parameswaran

AU - Carreras, Jeanette

AU - Zhang, Mei Jie

AU - Gale, Robert Peter

AU - Bolwell, Brian J.

AU - Bredeson, Christopher N.

AU - Burns, Linda J.

AU - Cairo, Mitchell S.

AU - Freytes, César O.

AU - Goldstein, Steven C.

AU - Hale, Gregory A.

AU - Inwards, David J.

AU - LeMaistre, Charles F.

AU - Maharaj, Dipnarine

AU - Marks, David I.

AU - Schouten, Harry C.

AU - Slavin, Shimon

AU - Vose, Julie Marie

AU - Lazarus, Hillard M.

AU - van Besien, Koen

PY - 2008/2/1

Y1 - 2008/2/1

N2 - Reduced-intensity conditioning (RIC) regimens have been increasingly used for allogeneic hematopoietic stem cell transplantation (HSCT) in follicular lymphoma (FL). We compared traditional myeloablative conditioning regimens to RIC in FL. Outcomes of HLA-identical sibling HSCT for FL in 208 recipients reported to the Center for International Blood and Marrow Transplant Research (CIBMTR) between 1997 and 2002 were studied. Conditioning regimens were categorized as myeloablative (N = 120) or RIC (N = 88). Use of RIC regimens increased from <10% of transplants in 1997 to >80% in 2002 signaling a major shift in practice. Patients receiving RIC were older and had a longer interval from diagnosis to transplant. These differences did not correlate with outcomes. Median follow-up of survivors was 50 months (4-96 months) after myeloablative conditioning versus 35 months (4-82 months) after RIC (P < .001). At 3 years, overall survival (OS) for the myeloablative and RIC cohorts were 71 (63%-79%) and 62 (51%-72%; P = .15) and progression free survival (PFS), 67 (58%-75%) and 55 (44%-65%; P = .07), respectively. Lower Karnofsky performance score (KPS) and resistance to chemotherapy were associated with higher treatment-related mortality (TRM) and lower OS and PFS. On multivariate analysis, an increased risk of lymphoma progression after RIC was observed (relative risk = 2.97, P = .04). RIC has become the de facto standard in allogeneic HSCT for FL, and appears to result in similar long-term outcomes. Although disease-free survival (DPS) is similar compared to myeloablative conditioning, an increased risk of late disease progression after RIC is concerning.

AB - Reduced-intensity conditioning (RIC) regimens have been increasingly used for allogeneic hematopoietic stem cell transplantation (HSCT) in follicular lymphoma (FL). We compared traditional myeloablative conditioning regimens to RIC in FL. Outcomes of HLA-identical sibling HSCT for FL in 208 recipients reported to the Center for International Blood and Marrow Transplant Research (CIBMTR) between 1997 and 2002 were studied. Conditioning regimens were categorized as myeloablative (N = 120) or RIC (N = 88). Use of RIC regimens increased from <10% of transplants in 1997 to >80% in 2002 signaling a major shift in practice. Patients receiving RIC were older and had a longer interval from diagnosis to transplant. These differences did not correlate with outcomes. Median follow-up of survivors was 50 months (4-96 months) after myeloablative conditioning versus 35 months (4-82 months) after RIC (P < .001). At 3 years, overall survival (OS) for the myeloablative and RIC cohorts were 71 (63%-79%) and 62 (51%-72%; P = .15) and progression free survival (PFS), 67 (58%-75%) and 55 (44%-65%; P = .07), respectively. Lower Karnofsky performance score (KPS) and resistance to chemotherapy were associated with higher treatment-related mortality (TRM) and lower OS and PFS. On multivariate analysis, an increased risk of lymphoma progression after RIC was observed (relative risk = 2.97, P = .04). RIC has become the de facto standard in allogeneic HSCT for FL, and appears to result in similar long-term outcomes. Although disease-free survival (DPS) is similar compared to myeloablative conditioning, an increased risk of late disease progression after RIC is concerning.

KW - Allogeneic

KW - Follicular lymphoma

KW - Nonmyeloablative

UR - http://www.scopus.com/inward/record.url?scp=38149063716&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=38149063716&partnerID=8YFLogxK

U2 - 10.1016/j.bbmt.2007.11.004

DO - 10.1016/j.bbmt.2007.11.004

M3 - Article

C2 - 18215784

AN - SCOPUS:38149063716

VL - 14

SP - 236

EP - 245

JO - Biology of Blood and Marrow Transplantation

JF - Biology of Blood and Marrow Transplantation

SN - 1083-8791

IS - 2

ER -